Endothelial therapy of atherosclerosis and its risk factors.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Current Vascular Pharmacology

• Publication date

  2003-05-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.2174/1570161033476763PMID 15320838
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Obesity-associated activation of angiotensin and endothelin in the cardiovascular system.

  2003cited by this paper
• Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.

  2002cited by this paper
• Chlamydia pneumoniae-atherosclerosis link: a sound concept in search for clinical relevance.

  2002cited by this paper
• A comparison of candesartan, felodipine, and their combination in the treatment of elderly patients with systolic hypertension.

  2002cited by this paper
• Obesity hypertension in children: a problem of epidemic proportions.

  2002cited by this paper
• Cigarette Smoke Induces Rapid Changes in Gene Expression in Pulmonary Arteries

  2002cited by this paper
• The Global Epidemic of Atherosclerotic Cardiovascular Disease

  2002cited by this paper
• Exercise to reduce cardiovascular risk--how much is enough?

  2002cited by this paper
• Inflammation and Atherosclerosis

  2002cited by this paper
• Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease.

  2002cited by this paper
• Association of circulating Chlamydia pneumoniae DNA with cardiovascular disease: a systematic review

  2002cited by this paper
• Stabilization of atherosclerotic plaques: New mechanisms and clinical targets

  2002cited by this paper
• Direct modulatory effect of C‐reactive protein on primary human monocyte adhesion to human endothelial cells

  2002cited by this paper
• Role of endothelin-1 and thromboxane A2 in renal vasoconstriction induced by angiotensin II in diabetes and hypertension.

  2002cited by this paper
• Effects of obesity on endothelium-dependent reactivity during acute nitric oxide synthase inhibition: modulatory role of endothelin.

  2002cited by this paper
• Low doses of angiotensin converting enzyme inhibitors and angiotensin type 1 blockers have a synergistic effect but high doses are less than additive.

  2002cited by this paper
• Obesity increases prostanoid-mediated vasoconstriction and vascular thromboxane receptor gene expression

  2002cited by this paper
• Statins and ischemic stroke.

  2002cited by this paper
• Effect of Controlled Release/Extended Release Metoprolol on Carotid Intima-Media Thickness in Patients With Hypercholesterolemia: A 3-Year Randomized Study

  2002cited by this paper
• Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors

  2002cited by this paper
• Walking compared with vigorous exercise for the prevention of cardiovascular events in women.

  2002cited by this paper
• A Review of Vasopeptidase Inhibitors: A New Modality in the Treatment of Hypertension and Chronic Heart Failure

  2002cited by this paper
• Increased local angiotensin II formation in aneurysmal aorta.

  2002cited by this paper
• Vasopeptidase inhibition: Effective blood pressure control for vascular protection

  2002cited by this paper
• The Renin-Angiotensin System and Progression of Renal Disease: From Hemodynamics to Cell Biology

  2002cited by this paper
• Obesity and the risk of heart failure.

  2002cited by this paper
• Reducing the global burden of cardiovascular disease: the role of risk factors.

  2002cited by this paper
• New therapeutics that antagonize endothelin: promises and frustrations

  2002cited by this paper
• Influenza A and B IgG seropositivity and coronary atherosclerosis assessed by angiography.

  2002cited by this paper
• Angiotensin II injures the arterial wall causing increased aortic stiffening in apolipoprotein E-deficient mice.

  2002cited by this paper
• Demonstration That C-Reactive Protein Decreases eNOS Expression and Bioactivity in Human Aortic Endothelial Cells

  2002cited by this paper
• C-Reactive Protein Relaxes Human Vessels In Vitro

  2002cited by this paper
• A Self-Fulfilling Prophecy: C-Reactive Protein Attenuates Nitric Oxide Production and Inhibits Angiogenesis

  2002cited by this paper
• Vasomotor and vascular effects of hormone replacement therapy.

  2002cited by this paper
• Physical Training Increases eNOS Vascular Expression and Activity and Reduces Restenosis After Balloon Angioplasty or Arterial Stenting in Rats

  2002cited by this paper
• Influenza Infection Promotes Macrophage Traffic Into Arteries of Mice That Is Prevented by D-4F, an Apolipoprotein A-I Mimetic Peptide

  2002cited by this paper
• Nanobacteria and calcinosis cutis

  2002cited by this paper
• The role of the renin-angiotensin system in the development of cardiovascular disease.

  2002cited by this paper
• Evolving strategies for renoprotection: diabetic nephropathy

  2001cited by this paper
• Age-Related Reduction of NO Availability and Oxidative Stress in Humans

  2001cited by this paper
• Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis

  2001cited by this paper
• Antagonism of AT2 receptors augments Angiotensin II‐induced abdominal aortic aneurysms and atherosclerosis

  2001cited by this paper
• Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice

  2001cited by this paper
• Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors.

  2001cited by this paper
• Role of endothelin-1 in hypertension and vascular disease.

  2001cited by this paper
• Statin therapy: where are we? Where do we go next?

  2001cited by this paper
• Reduction of Isoprostanes and Regression of Advanced Atherosclerosis by Apolipoprotein E*

  2001cited by this paper
• Increased expression of endothelin-1 and inducible nitric oxide synthase isoform II in aging arteries in vivo: implications for atherosclerosis.

  2001cited by this paper
• Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

  2001cited by this paper
• What have we learned about the biology of atherosclerosis? The role of inflammation.

  2001cited by this paper
• Endothelial Atheroprotective and Anti‐inflammatory Mechanisms

  2001cited by this paper
• Angiotensin II and atherosclerosis.

  2001cited by this paper
• The therapeutic potential of endothelin receptor antagonists in cardiovascular disease

  2001cited by this paper
• Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis.

  2000cited by this paper
• The good smooth muscle cells in atherosclerosis

  2000cited by this paper
• Endothelial dysfunctions: common denominators in vascular disease.

  2000cited by this paper
• Modulation of Protein Kinase Activity and Gene Expression by Reactive Oxygen Species and Their Role in Vascular Physiology and Pathophysiology

  2000cited by this paper
• Losartan inhibits cellular uptake of oxidized LDL by monocyte-macrophages from hypercholesterolemic patients.

  2000cited by this paper
• Role of NAD(P)H Oxidase in Angiotensin II–Induced JAK/STAT Signaling and Cytokine Induction

  2000cited by this paper
• Obesity is associated with tissue-specific activation of renal angiotensin-converting enzyme in vivo: evidence for a regulatory role of endothelin.

  2000cited by this paper
• NAD(P)H oxidase: role in cardiovascular biology and disease.

  2000cited by this paper
• Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability.

  2000cited by this paper
• Cyclo-oxygenase products and atherothrombosis.

  2000cited by this paper
• Endothelins and Endothelin Receptor Antagonists: Therapeutic Considerations for a Novel Class of Cardiovascular Drugs

  2000cited by this paper
• Vascular endothelial growth factor and osteopontin in tumor biology.

  2000cited by this paper
• Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice.

  2000cited by this paper
• Folic acid reverts dysfunction of endothelial nitric oxide synthase.

  2000cited by this paper
• Superoxide Reacts with Nitric Oxide to Nitrate Tyrosine at Physiological pH via Peroxynitrite*

  2000cited by this paper
• Say NO to ET.

  2000cited by this paper
• Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats.

  1999cited by this paper
• Effect of the HMG-CoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia.

  1999cited by this paper
• Chemokines and atherosclerosis.

  1999cited by this paper
• The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice.

  1999cited by this paper
• WIZARD and the design of trials for secondary prevention of atherosclerosis with antibiotics.

  1999cited by this paper
• Additional reduction in blood pressure after cholesterol-lowering treatment by statins (lovastatin or pravastatin) in hypercholesterolemic patients using angiotensin-converting enzyme inhibitors (enalapril or lisinopril).

  1999cited by this paper
• State-of-the-Art lecture. Statins and blockers of the renin-angiotensin system: vascular protection beyond their primary mode of action.

  1999cited by this paper
• Enhanced reduction of atherosclerosis in hamsters treated with pravastatin and captopril: ACE in atheromas provides cellular targets for captopril.

  1998cited by this paper
• The discovery of endothelins.

  1998cited by this paper
• Antiatherosclerotic and antioxidative effects of captopril in apolipoprotein E-deficient mice.

  1998cited by this paper
• Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice.

  1998cited by this paper
• Childhood weight affects adult morbidity and mortality.

  1998cited by this paper
• Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

  1998cited by this paper
• Atherosclerosis is an Inflammatory Disease

  1998cited by this paper
• Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo.

  1998cited by this paper
• Global epidemic of cardiovascular disease predicted.

  1998cited by this paper
• Peroxynitrite-mediated vasorelaxation: evidence against the formation of circulating S-nitrosothiols.

  1998cited by this paper
• ETA Receptor Blockade Prevents Increased Tissue Endothelin-1, Vascular Hypertrophy, and Endothelial Dysfunction in Salt-Sensitive Hypertension

  1998cited by this paper
• Anatomic heterogeneity of vascular aging: role of nitric oxide and endothelin.

  1997cited by this paper
• Cellular and molecular mechanisms of endothelial cell dysfunction.

  1997cited by this paper
• Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions.

  1997cited by this paper
• Improvement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus.

  1997cited by this paper
• Biology of the Endothelium

  1997cited by this paper
• Estrogen inhibits endothelin-1 production and c-fos gene expression in rat aorta.

  1996cited by this paper
• Angiotensin Converting Enzyme Inhibition, with Quinapril, Improves Endothelial Vasomotor Dysfunction in Patients with Coronary Artery Disease: the TREND Study (Trial on REversing ENdothelial Dysfunction)

  1996cited by this paper
• Effect of age on kinetics of nitric oxide release in rat aorta and pulmonary artery.

  1996cited by this paper
• Different mechanisms of endothelial dysfunction with aging and hypertension in rat aorta.

  1995cited by this paper
• Diabetes mellitus and associated hypertension, vascular disease, and nephropathy. An update.

  1995cited by this paper
• Aging and endothelial function in normotensive subjects and patients with essential hypertension.

  1995cited by this paper
• Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.

  1995cited by this paper
• Diminished Vascular Response to Inhibition of Endothelium‐Derived Nitric Oxide and Enhanced Vasoconstriction to Exogenously Administered Endothelin‐1 in Clinically Healthy Smokers

  1994cited by this paper

• Role of Nitric Oxide and Protein S-Nitrosylation in Ischemia-Reperfusion Injury

  2021cites this paper
• Endothelin-1 axes in the framework of predictive, preventive and personalised (3P) medicine

  2021cites this paper
• Ginsenoside Rb1 Prevents Dysfunction of Endothelial Cells by Suppressing Inflammatory Response and Apoptosis in the High-Fat Diet Plus Balloon Catheter-Injured Rabbit Model via the G Protein-Coupled Estrogen Receptor-Mediated Phosphatidylinositol 3-Kinases (PI3K)/Akt Pathway

  2019cites this paper
• The Effect of Circuit Resistance Training on Plasma Concentration of Endothelin-1, Nitric Oxide and Vascular Diameter in Elderly Men

  2019cites this paper
• Effect of dietary fat restriction on vascular function

  2017cites this paper
• Accelerated Vascular Aging as a Paradigm for Hypertensive Vascular Disease: Prevention and Therapy.

  2016cites this paper
• Endothelial Dysfunction: Clinical Implications in Cardiovascular Disease and Therapeutic Approaches

  2015cites this paper
• Antioxidant Foods and Diseases : Natural Antioxidants for Healthy Life

  2014cites this paper
• Aging and endothelin: determinants of disease.

  2014cites this paper
• Prevention and endothelial therapy of coronary artery disease.

  2013cites this paper
• Obesity and risk of vascular disease: importance of endothelium‐dependent vasoconstriction

  2012influential citation
• Endothelial and Vascular Smooth Cell Dysfunctions: A Comprehensive Appraisal

  2012cites this paper
• Benefit of immediate revascularization in women with critical limb ischemia in an intention-to-treat analysis.

  2011cites this paper
• Astaxanthin inhibits thrombosis in cerebral vessels of stroke-prone spontaneously hypertensive rats.

  2011cites this paper
• Phosphodiesterases as targets for intermittent claudication.

  2011cites this paper
• The discovery of endothelium-dependent contraction: the legacy of Paul M. Vanhoutte.

  2011cites this paper
• Obesity and aging: determinants of endothelial cell dysfunction and atherosclerosis

  2010influential citation
• Anti-Inflammatory Effects of Endothelin Receptor Antagonists and their Importance for Treating Human Disease

  2010cites this paper
• THEMED SECTION: ENDOTHELIUM IN PHARMACOLOGY RESEARCH PAPER Increased endothelin-1 reactivity and endothelial dysfunction in carotid arteries from rats with hyperhomocysteinemia

  2009cites this paper
• Increased endothelin‐1 reactivity and endothelial dysfunction in carotid arteries from rats with hyperhomocysteinemia

  2009cites this paper
• Prognostic role of flow-mediated dilation and cardiac risk factors in post-menopausal women.

  2008cites this paper
• Symptomatic acute myocardial infarction in a patient bearer of heart transplantation following ischemic heart disease.

  2008cites this paper
• Isolation of endothelial cells and vascular smooth muscle cells from internal mammary artery tissue.

  2007cites this paper
• Recent developments on endothelin antagonists as immunomodulatory drugs--from infection to transplantation medicine.

  2006cites this paper
• Alpha1D-adrenoceptor-induced relaxation on rat carotid artery is impaired during the endothelial dysfunction evoked in the early stages of hyperhomocysteinemia.

  2006cites this paper
• Blood clotting, inflammation, and thrombosis in cardiovascular events: perspectives.

  2006cites this paper
• Funkcja śródbłonka u osób z chorobami układu krążenia. Część I: czynniki humoralne i badanie funkcji śródbłonka Endothelial function in patients with cardiovascular diseases. Part I: humoral factors and assessment of endothelial function

  2005cites this paper
• Protease-activated receptors and EDHF: the icing on the cake?

  2004cites this paper